Obesity and dose individualization in cancer chemotherapy: The role of body surface area and body mass index

Medical Hypotheses

Volumn 65, Issue 4, 2005, Pages 748-751

  Portugal, Rodrigo Doyle ^a  

^a Hospital Universitario   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BODY MASS; BODY SURFACE; CANCER CHEMOTHERAPY; CANCER PATIENT; DOSE CALCULATION; MATHEMATICAL COMPUTING; OBESITY; PRIORITY JOURNAL;

BODY MASS INDEX; BODY SURFACE AREA; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; OBESITY;

EID: 22544476830     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.04.023     Document Type: Article

References (18)

1. M.L. Baskin, J. Ard, F. Franklin, and D.B. Allison Prevalence of obesity in the United States Obes Rev 6 2005 5 7
2. E.E. Calle, and M.J. Thun Obesity and cancer Oncogene 23 2004 6365 6378
3. S.M. Enger, J.M. Greif, J. Polikoff, and M. Press Body weight correlates with mortality in early-stage breast cancer Arch Surg 139 2004 954 958
4. D. DuBois, and E.F. DuBois A formula to estimate the approximate surface area if height and weight be known Arch Intern Med 17 1916 863 871
5. E.A. Gehan, and S.L. George Estimation of human body surface area from height and weight Cancer Chemother Rep 54 1970 225 235
6. G. Powis, P. Reece, D.L. Ahmann, and J.N. Ingle Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients Cancer Chemother Pharmacol 20 1987 219 222
7. K.A. Rodvold, D.A. Rushing, and D.A. Tewksbury Doxorubicin clearance in the obese J Clin Oncol 6 1998 1321 1327
8. R. Abdah-Bortnyak, M. Tsalic, and N. Haim Actual body weight for determining doses of chemotherapy in obese cancer patients: evaluation of treatment tolerability Med Oncol 20 2003 363 368
9. M.S. Georgiadis, S.M. Steinberg, L.A. Hankins, D.C. Ihde, and B.E. Johnson Obesity and therapy-related toxicity in patients treated for small-cell lung cancer J Natl Cancer Inst 87 1995 361 366
10. G.L. Rosner, J.B. Hargis, D.R. Hollis, D.R. Budman, R.B. Weiss, and I.C. Henderson Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemiax group B study 8541 J Clin Oncol 14 1996 3000 3008
11. J.A. Meyerhardt, P.J. Catalano, D.G. Haller, R.J. Mayer, A.B. Benson 3rd, and J.S. Macdonald Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma Cancer 98 2003 484 495
12. B.J. Lange, R.B. Gerbing, J. Feusner, J. Skolnik, N. Sacks, and F.O. Smith Mortality in overweight and underweight children with acute myeloid leukemia JAMA 293 2005 203 211
13. M.E. De Jonge, R.A. Mathot, S.M. Van Dam, J.H. Beijnen, and S. Rodenhuis Extremely high exposures in an obese patient receiving high-dose cyclophosphamide, thiotepa and carboplatin Cancer Chemother Pharmacol 50 2002 251 255
14. G. Meloni, A. Proia, S. Capria, A. Romano, G. Trape, and S.M. Trisolini Obesity and autologous stem cell transplantation in acute myeloid leukemia Bone Marrow Transplant 28 2001 365 367
15. P. Canal, E. Chatelut, and S. Guichard Practical treatment guide for dose individualisation in cancer chemotherapy Drugs 56 1998 1019 1038
16. R.D. Mosteller Simplified calculation of body surface area N Engl J Med 317 1987 1098
17. T. Kouno, N. Katsumata, H. Mukai, M. Ando, and T. Watanabe Standardization of the body surface area (BSA) formula to calculate the dose of anticancer agents in Japan Jpn J Clin Oncol 33 2003 30913
18. R.S. Gelman, D.C. Tormey, and R. Betensky Actual versus ideal weight in the calculation of surface area: effects on dose of 11 chemotherapy agents Cancer Treat Rep 71 1987 907 911